GlassScriptPhysician profile
Renee Tran Chen
NPI 1760804157
$1,179.06
in general payments reported to CMS, 2019-2025
23 companies · $94.28 in 2025
The $94.28 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $190 · 2021: $34.84 · 2022: $285 · 2023: $78.20 · 2024: $66.09 · 2025: $94.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $203.67 | 2020-2023 | Lo Loestrin Fe |
| Duchesnay USA Incorporated | $129.27 | 2019 | |
| Medical Device Business Services, INC. | $123.48 | 2019 | |
| Hologic Sales and Service, LLC | $86.51 | 2022-2025 | Omni Hysteroscope, Novasure, Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $75.95 | 2019 | |
| Therapeuticsmd, INC. | $74.75 | 2019-2020 | |
| Pfizer INC. | $57.52 | 2022-2024 | |
| Coopersurgical, INC. | $49.06 | 2019-2023 | Mara Console |
| Mayne Pharma Commercial LLC | $46.51 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.92 | 2019-2022 | |
| Organon LLC | $27.93 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $26.75 | 2022 | |
| Ethicon US, LLC | $26.29 | 2022 | |
| Baxter Healthcare | $25.66 | 2020 | |
| Janssen Pharmaceuticals, INC | $25.56 | 2023 | Xarelto |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $24.49 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $24.29 | 2025 | Uzedy |
| Shield Therapeutics INC | $23.80 | 2022 | |
| Aspira Women'S Health INC | $21.75 | 2023 | Ova1 |
| Recordati_rare_diseases_inc. | $20.60 | 2025 | Isturisa |
| Lupin INC. | $13.51 | 2020 | |
| Allergan, INC. | $13.43 | 2019 | |
| Daiichi Sankyo INC. | $12.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.